- Home
- About Us
- Divisions
- Adolescent and Young Adult Medicine
- Allergy and Immunology
- Blood and Marrow Transplantation and Cellular Therapies
- Cardiology
- Child Advocacy
- Emergency Medicine
- Endocrinology
- Gastroenterology, Hepatology and Nutrition
- General Academic Pediatrics
- Genetic and Genomic Medicine
- Health Informatics
- Hematology-Oncology
- Infectious Diseases
- Nephrology
- Neurology and Child Development
- Newborn Medicine
- Paul C. Gaffney Division of Pediatric Hospital Medicine
- Pulmonology
- Rheumatology
- Centers & Institutes
- Center for Pediatric Research in Obesity and Metabolism
- Center for Rare Disease Therapy
- Children's Neuroscience Institute
- Cystic Fibrosis Research Center
- Institute for Infection, Inflammation, and Immunity in Children
- Pediatric Asthma Center
- Pediatric Institute for Heart Regeneration and Therapeutics
- Richard King Mellon Foundation Institute for Pediatric Research
- Pittsburgh Vaccine Trials Unit
- The Pittsburgh Study
- Research
- Diversity
- Education
- Faculty Affairs
- News
- People
- Podcasts
Lisa Maurer, MD, PhD
- Assistant Professor of Pediatrics
Administrative Assistant: Carla Clarke
Dr. Maurer is a pediatric oncologist with an interest in pediatric leukemia and lymphoma. She is also a physician-scientist in the Lucas/ McAllister Lab in the Rangos Research Center of the UPMC Children's Hospital of Pittsburgh. Currently, Dr. Maurer's research focus is on the role of GRK2 in inhibition of the MALT1 proto-oncoprotein in lymphomagenesis.
Professional and Scientific Society Memberships
- American Society of Pediatric Hematology Oncology 2016-present
- AACR 2019-present
Education & Training
- BA, Kenyon College, 2004
- PhD, University of Wisconsin-Madison, 2013
- MD, University of Wisconsin School of Medicine and Public Health
- Internship and Residency, University of California San Francisco, 2016
- Fellowship, UPMC Children's Hospital of Pittsburgh
Selected Publications
Kirkpatrick C, Maurer LM, Oyelakin N, Yoncheve YN, Maurer R, Slonczewski JL. 2001. Acetate and formate stress: Opposite responses in the proteome of Escherichia coli. J Bacteriol. 183(21):6466-6477. PMID: 11591692.
Abram CL, Seals DF, Pass I, Salinsky D, Maurer L, Roth TM, Courtneidge SA. 2003. The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells. J Biol Chem 278(19):16844-16851. PMID: 12615925.
Maurer LM, Yohannes E, Bondurant SS, Radmacher M, Slonczewski JL. 2005. pH regulates genes for flagellar motility, catabolism, and oxidative stress in Escherichia coli K-12. J Bacteriol. 187(1):304-319. PMID: 15601715.
Xu J, Maurer LM, Hoffmann BR, Annis DS, Mosher DF. 2010. iso-DGR sequences do not mediate binding of fibronectin N-terminal modules to adherent fibronectin-null fibroblasts. J Biol Chem. 285(12):8563-8571. PMID: 20097751.
Maurer LM, Tomasini-Johansson BR, Ma W, Annis DS, Eickstaedt NL, Ensenberger MG, Satyshur KA, Mosher DF. 2010. Extended binding site on fibronectin for the functional upstream domain of protein F1 of Streptococcus pyogenes. J Biol Chem. 285(33):41087-41099. PMID: 20947497.
Maurer LM, Annis DS, Mosher DF. 2012. IGD motifs, which are required for migration stimulatory activity of fibronectin type I modules, do not mediate binding in matrix assembly. PLoS ONE. 7(2):e30615. PMID: 22355321.
Maurer LM, Ma W, Eickstaedt NL, Johnson IA, Tomasini-Johansson BR, Annis DS, Mosher DF. 2012. Ligation of the fibrin-binding domain by b-Strand Addition is sufficient for expansion of soluble fibronectin. J Biol Chem. 287(16):13303-13312. PMID: 22351755.
Moussavi-Harami SF, Annis DS, Ma W, Berry SM, Coughlin EE, Strotman LN, Maurer LM, Westphall MS, Coon JJ, Mosher DF, Beebe DJ. 2013. Characterization of Molecules Binding to the 70K N-Terminal Region of Fibronectin by IFAST Purification Coupled with Mass Spectrometry. J Proteome Res. 12(7):3393-404. PMID: 23750785.
Harris G, Ma W, Maurer LM, Potts JR, Mosher DF. 2014. Borrelia burgdorferi protein BBK32 binds to soluble fibronectin via the N-terminal 70 kDa region, causing fibronectin to undergo conformational extension. J Biol Chem. 289(32):22490-9. PMID: 24962582.
Cheng J, Klei LR, Hubel NE, Zhang M, Schairer R, Maurer LM, Klei HB, Kang H, Concel VJ, Delekta PC, Dang EV, Mintz M, Baens M, Cyster JG, Parameswaran N, Thome M, Lucas PC, and McAllister-Lucas LM. 2020. GRK2 functions as a tumor suppressor in lymphoma via inhibition of the MALT1 proto-oncoprotein. JCI. 130(2):1036 – 1051. PMID: 31961340.